1BMA. Recognising the Importance of Physical Health in Mental Health and Intellectual Disability. Achieving Parity of Outcomes. BMA Board of Science, 2014.
2Saha, S, Chant, D, McGrath, J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 2007; 64: 1123–31.
3Laursen, TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 2011; 131: 101–4.
4Correll, CU, Solmi, M, Veronese, N, Bortolato, B, Rosson, S, Santonastaso, P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017; 16: 163–80.
5Nolte, EC, Martin, M. Measuring the health of nations: updating an earlier analysis. Health Aff 2008; 27: 58–71.
6Goff, DC, Sullivan, LM, McEvoy, JP. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res 2005; 80: 45–53.
7De Hert, M, Schreurs, V, Vancampfort, D, Van Winkel, R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009; 8: 15–22.
8Filik, R, Sipos, A, Kehoe, PG, Burns, T, Cooper, SJ. The cardiovascular and respiratory health of people with schizophrenia. Acta Psychiatr Scand 2006; 113: 298–305.
9Allison, DB, Mentore, JL, Heo, M, Chandler, LP, Cappelleri, JC, Infante, MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–96.
10Stubbs, B, Firth, J, Berry, A, Schuch, FB, Rosenbaum, S, Gaughran, F, et al. How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res 2016; 176: 431–40.
11Barnes, TRE, Paton, C, Cavanagh, M, Hancock, E, Taylor, DM. A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophr Bull 2007; 33: 1397–403.
12Crawford, MJ, Jayakumar, S, Lemmey, SJ, Zalewska, K, Patel, MX, Cooper, SJ, et al. Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study. Br J Psychiatry 2014; 205: 473.
13National Institute for Health and Care Excellence. Psychosis and Schizophrenia in Adults: Prevention and Management. Clinical Guideline 178. NICE, 2014 (nice.org.uk/guidance/cg178). 14National Institute for Health and Care Excellence. Bipolar Disorder: Assessment and Management. Clinical Guideline 185. NICE, 2014 (nice.org.uk/guidance/cg185).
15Royal College of Psychiatrists. Report of the National Audit of Schizophrenia (NAS) 2012. Healthcare Quality Improvement Partnership, 2012.
16Basch, E, Schrag, D. The evolving uses of real-world data. The evolving uses of real-world data editorial. JAMA 2019; 321: 1359–60.
17Higgins, T. HbA1c for screening and diagnosis of diabetes mellitus. Endocrine 2013; 43: 266–73.
18National Institute for Health and Care Excellence. Preventing Type 2 Diabetes: Risk Identification and Interventions for Individuals at High Risk (NICE Public Health Guidance). NICE, 2012.
19Park, J, McAlaney, C, Connolly, M. Improving patient care and clinical governance through the utilisation of a clinical information system. Clin Governance 2008; 13: 254–60.
20ISD Scotland. Scottish Morbidity Records. ISD Scotland, 2019.
21World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. World Health Organization, 1992.
22Guy, W (ed). ECDEU Assessment Manual for Psychopharmacology. US Department of Heath, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, 1976.
23Wing, JK, Beevor, AS, Curtis, RH, Park, SB, Hadden, S, Burns, A. Health of the Nation Outcome Scales (HoNOS). Research and development. Br J Psychiatry 1998; 172: 11–18.
24Joint Formulary Committee. BNF 76: September 2018. Pharmaceutical Press, 2018.
26Scottish Health Survey 2011. Scottish Health Survey. The Scottish Government, 2011.
27Kilpatrick, ES, Atkin, SL. Using haemoglobin A1c to diagnose type 2 diabetes or to identify people at high risk of diabetes. BMJ 2014; 348: g2867.
28World Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus. WHO, 2011.
29Vancampfort, D, Correll, CU, Galling, B, Probst, M, De Hert, M, Ward, PB, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry 2016; 15: 166–74.